Biogen Shares Leap Following Korean Report of Deal Talks

Bloomberg2021-12-30

Biogen Inc.shares jumped by the most since the company’s Alzheimer’s disease treatment was approved in the U.S. this spring, after a Korean media report that it was in talks to sell itself to Samsung ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

jojoc
2021-12-30
jojoc
Ok

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1107504568?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-12-30 08:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1107504568","market":"us","top_or_hot":-1,"title":"Biogen Shares Leap Following Korean Report of Deal Talks","media":"Bloomberg","content":"<div>\n<p>Biogen Inc.shares jumped by the most since the company’s Alzheimer’s disease treatment was approved in the U.S. this spring, after a Korean media report that it was in talks to sell itself to Samsung ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-29/biogen-shares-leap-following-korean-report-of-deal-talks\">网页链接</a>\n\n</div>\n","source":"lsy1584095487587","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen Shares Leap Following Korean Report of Deal Talks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen Shares Leap Following Korean Report of Deal Talks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-30 08:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-29/biogen-shares-leap-following-korean-report-of-deal-talks><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biogen Inc.shares jumped by the most since the company’s Alzheimer’s disease treatment was approved in the U.S. this spring, after a Korean media report that it was in talks to sell itself to Samsung ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-29/biogen-shares-leap-following-korean-report-of-deal-talks\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BIIB","symbol_name":"渤健公司","start_time":0,"source_url":"https://www.bloomberg.com/news/articles/2021-12-29/biogen-shares-leap-following-korean-report-of-deal-talks","article_id":"1107504568","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1107504568","pubTimestamp":1640824341,"sourceInfo":{"source_id":"lsy1584095487587","name":"Bloomberg"},"weMediaInfo":null,"summary":"Biogen Inc.shares jumped by the most since the company’s Alzheimer’s disease treatment was approved ","collect":0,"end_time":0,"defaultTopTitle":"bloomberg.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BIIB":"渤健公司"},"translate_title":"韩国报道交易谈判后，生物基因股份跃升","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BIIB":0.9},"content_text":"Biogen Inc.shares jumped by the most since the company’s Alzheimer’s disease treatment was approved in the U.S. this spring, after a Korean media report that it was in talks to sell itself to Samsung Group.The Korea Economic Daily reported, citing unnamed sources, that the Cambridge, Massachusetts-based biotechnology company had approached the Seoul conglomerate about a takeover.A representative for Biogen said that the company doesn’t comment on market rumors and speculation. A spokesperson for Samsung Biologics Co., a biotech unit of the Samsung Group, said the story was a rumor and declined to comment further.Biogen’s stock gained as much as 13%, the biggest intraday advance since June 7, before ending the day up 9.5% at $258.31.A deal for Biogen, with a market value of $38 billion after Wednesday’s jump, would top the $34 billion Medline Industries Inc. transaction, now the second-biggest acquisition of 2021, according to data compiled by Bloomberg.With a typical premium, a Biogen acquisition would likely approach or surpass Discovery Inc.’s $43 billion deal for Warner Media LLC that was announced in May, the data show.Biogen gained approval for its Alzheimer’s treatment Aduhelm in June over the objections of experts who said there wasn’t enough clear evidence that it worked. Since then, the drug has struggled to gain momentum as patients and payers balked at the scientific debate and the treatment’s $56,000-a-year cost. Biogen has since cut the drug’s price in half.There are existing ties between the companies. Samsung Bioepis is a joint venture between Samsung Biologics and Biogen focused on making low-cost biosimiliars. Its version of macular degeneration treatment Lucentis was approved in the U.S. in September.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":692910148,"gmtCreate":1640825526083,"gmtModify":1640825526301,"author":{"id":"4099442649801160","authorId":"4099442649801160","name":"jojoc","avatar":"https://static.tigerbbs.com/ccc8519a0bdc4ba6b43a9aa8afa0e63c","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"4099442649801160","authorIdStr":"4099442649801160"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/692910148","repostId":1107504568,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":30,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1107504568"}